Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

[Symptoms of obsessive-compulsive disorder in neurological diseases].
Incidence, characterization, and clinical impact analysis of peginterferon beta1a immunogenicity in patients with multiple sclerosis in the ADVANCE trial.
IL-27 plasma level in relapsing remitting multiple sclerosis subjects: The double-faced cytokine.
Symmetry in vertical ground reaction force is not related to walking and balance difficulties in people with multiple sclerosis.
Grey matter atrophy is associated with disability increase in natalizumab-treated patients.
NMDA receptor antibodies: A rare association in inflammatory demyelinating diseases.
Journal Club: Effect of comorbidity on mortality in multiple sclerosis.
Epileptic Phenotype of Two Siblings with Asparagine Synthesis Deficiency Mimics Neonatal Pyridoxine-Dependent Epilepsy.
Cognitive motor interference in multiple sclerosis: Insights from a systematic, quantitative review.
Heterogeneity in oligodendroglia: Is it relevant to mouse models and human disease?
Virtual street-crossing performance in persons with multiple sclerosis: Feasibility and task performance characteristics.
Preferential conduction block of myelinated axons by nitric oxide.
[Fingolimod: effectiveness and safety in routine clinical practice. An observational, retrospective, multi-centre study in the province of Alicante].
The Gut Microbiota in Immune-Mediated Inflammatory Diseases.
Efficacy of N-Acetylserotonin and Melatonin in the EAE Model of Multiple Sclerosis.
Activation of the niacin receptor HCA reduces demyelination and neurofilament loss, and promotes functional recovery after spinal cord injury in mice.
Assessing and treating pain associated with stroke, multiple sclerosis, cerebral palsy, spinal cord injury and spasticity. Evidence and recommendations from the Italian Consensus conference on Pain in Neurorehabilitation.
Hormone replacement in menopausal women with multiple sclerosis: Looking back, thinking forward.
Type I interferon causes thrombotic microangiopathy by a dose-dependent toxic effect on the microvasculature.
Cognitive Impairment in Multiple Sclerosis.
Neuroleptic Malignant Syndrome Associated with Refractory Acute Disseminated Encephalomyelitis.
Global progress in the control of viral hepatitis and acceptable delay in Hepatitis B immunization.
Monooxygenase substrates mimic flavin to catalyze cofactorless oxygenations.
Th1, Th2 and Th17 Cytokine Profile in Patients with Multiple Sclerosis Following Treatment with Rapamycin.
YAP and TAZ control peripheral myelination and the expression of laminin receptors in Schwann cells.

Pages